Literature DB >> 7549061

Clinical features of nosocomial rotavirus infection in pediatric liver transplant recipients.

S W Fitts1, M Green, J Reyes, B Nour, A G Tzakis, S A Kocoshis.   

Abstract

A retrospective survey of nosocomial rotavirus infection in pediatric liver transplant recipients was performed. Immunocompetent children with nosocomial infections served as controls. Co-pathogens were not identified. A total of 12 transplant cases and 12 controls could be evaluated. New onset vomiting occurred in 7/8 cases and 6/11 controls lasting an average of 2.8 days per case and 0.8 days per control (p < .05). New onset fever (>38 degrees C) was noted in 8/12 cases and 9/12 controls. New onset occult blood was noted in 7/11 cases and 1/12 controls (p < .01). A concomitant rise and fall in transaminases was noted in 5/12 transplant recipients. Eleven of the 12 were maintained on constant or increased immunosuppression doses without the development of fulminant disease. The presence of increased days of vomiting and occult blood in stools suggests that rotavirus causes a more invasive process in the intestinal mucosa of transplant recipients compared to immunocompetent children. However, the process remains self-limited despite the use of potent immunosuppressives.

Entities:  

Mesh:

Year:  1995        PMID: 7549061

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  8 in total

1.  Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains.

Authors:  M Ciarlet; S E Crawford; M K Estes
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Complications in hospitalized children with acute gastroenteritis caused by rotavirus: a retrospective analysis.

Authors:  Petra Kaiser; Michael Borte; Klaus-Peter Zimmer; Hans-Iko Huppertz
Journal:  Eur J Pediatr       Date:  2011-08-11       Impact factor: 3.183

3.  VLA-2 (alpha2beta1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment.

Authors:  Max Ciarlet; Sue E Crawford; Elly Cheng; Sarah E Blutt; Daren A Rice; Jeffrey M Bergelson; Mary K Estes
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

4.  Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine.

Authors:  Catherine Yen; Kathleen Jakob; Mathew D Esona; Ximara Peckham; John Rausch; Jennifer J Hull; Susan Whittier; Jon R Gentsch; Philip LaRussa
Journal:  Vaccine       Date:  2011-04-06       Impact factor: 3.641

5.  Incidence of Hospitalization for Vaccine-Preventable Infections in Children Following Solid Organ Transplant and Associated Morbidity, Mortality, and Costs.

Authors:  Amy G Feldman; Brenda L Beaty; Donna Curtis; Elizabeth Juarez-Colunga; Allison Kempe
Journal:  JAMA Pediatr       Date:  2019-03-01       Impact factor: 16.193

6.  Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics.

Authors:  Sandrine Leroy; Arnaud Isapof; Sonia Fargue; May Fakhoury; Albert Bensman; Georges Deschênes; Evelyne Jacqz-Aigrain; Tim Ulinski
Journal:  Pediatr Nephrol       Date:  2010-01-21       Impact factor: 3.714

Review 7.  Under-immunization of pediatric transplant recipients: a call to action for the pediatric community.

Authors:  Amy G Feldman; Donna J Curtis; Susan L Moore; Allison Kempe
Journal:  Pediatr Res       Date:  2019-07-22       Impact factor: 3.756

8.  Immunization status and hospitalization for vaccine-preventable and non-vaccine-preventable infections in liver-transplanted children.

Authors:  Palittiya Sintusek; Yong Poovorawan
Journal:  World J Hepatol       Date:  2021-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.